Table 1.
Associated features of normotension, white coat syndrome, and hypertension
Features | Normotension | White coat effect | White coat hypertension | Masked hypertension | Hypertension | |
---|---|---|---|---|---|---|
Within normal BP limits | Exceeding normal BP limits | |||||
Office BP levels | ≤120/80 mmHg16 | >20/10 mmHg when compared to home measurements14 | ≥140/90 mmHg38 | <140/90 mmHg38 | <140/90 mmHg16 | ≥140/90 mmHg15 |
24 hours ABPM levels | <130/80 mmHg16 | <130/80 mmHg14 | <130/80 mmHg38 | ≥130/80 mmHg38 | <130/80 mmHg16 | ≥130/80 mmHg15 |
HBPM levels | <135/85 mmHg16 | ≤135/85 mmHg14 | <135/85 mmHg38 | ≥135/85 mmHg38 | <135/85 mmHg16 | ≥135/85 mmHg15 |
Clinical characteristics | – | Higher heart rate levels and BP non-dipping condition17 | Higher in female sex, obese, and it seems to increase with respect to age24 | Increased risk of atherosclerotic CVD,41 morbidity, and mortality for CVD43,44 | Sustained elevated BP levels are related to the development of TOD and, consequently, increased CV risk25 | |
Target organ damage | – | Low relationship with TOD development;22 correlation with arterial stiffness20,21 | Correlation with arterial stiffness28 and LVH34 | Presents a higher risk of developing TOD than other phenomena but less risk than hypertensive11 | LVH, diastolic dysfunction, carotid intima-media thickening or plaque, renal damage, and micro- as well as macro-vascular alterations24 |
Abbreviations: ABPM, ambulatory BP monitoring; BP, blood pressure; CV, cardiovascular risk; CVD, cardiovascular disease; HBPM, home BP monitoring; LVH, left ventricular hypertrophy; TOD, target organ damage.